Jun Arai

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Drug Administration

Clostridium Difficile

Radiofrequency Ablation

Mesenchymal Stem Cells

Top Venues

Hepatology research : the official journal of the Japan Society of Hepatology

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jun Arai, Akinori Okumura, Naoya Kato, Kiyoaki Ito
Natural killer group 2D-major histocompatibility complex class I polypeptide-related sequence A activation enhances natural killer cell-mediated immunity against hepatocellular carcinoma: A review. Hepatology research : the official journal of the Japan Society of Hepatology (2024)
Jun Arai, Akinori Okumura, Naoya Kato, Kiyoaki Ito
Natural killer group 2D-major histocompatibility complex class I polypeptide-related sequence A activation enhances natural killer cell-mediated immunity against hepatocellular carcinoma: A review. Hepatology research : the official journal of the Japan Society of Hepatology 54 (5) (2024)
Jun Arai, Akinori Okumura, Naoya Kato, Kiyoaki Ito
Natural killer group 2D-major histocompatibility complex class I polypeptide-related sequence A activation enhances natural killer cell-mediated immunity against hepatocellular carcinoma: A review. Hepatology research : the official journal of the Japan Society of Hepatology 54 (5) (2024)
Jun Arai, Yumi Otoyama, Hisako Nozawa, Naoya Kato, Hitoshi Yoshida
The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review. Oncogene 42 (8) (2022)
Jun Arai, Yumi Otoyama, Hisako Nozawa, Naoya Kato, Hitoshi Yoshida
The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review. Oncogene (2022)
Jun Arai, Yumi Otoyama, Hisako Nozawa, Naoya Kato, Hitoshi Yoshida
The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review. Oncogene (2022)
Jun Arai, Yumi Otoyama, Hisako Nozawa, Naoya Kato, Hitoshi Yoshida
The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review. Oncogene 42 (8) (2022)
Jun Arai, Yumi Otoyama, Hisako Nozawa, Naoya Kato, Hitoshi Yoshida
The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review. Oncogene 42 (8) (2022)
Jun Arai, Yumi Otoyama, Hisako Nozawa, Naoya Kato, Hitoshi Yoshida
The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review. Oncogene (2022)
Takahiro Fuji, Jun Arai, Yumi Otoyama, Yuta Nio, Ikuya Sugiura, Yoko Nakajima, Atsushi Kajiwara, Yuki Ichikawa, Shojiro Uozumi, Yuu Shimozuma, Manabu Uchikoshi, Masashi Sakaki, Hisako Nozawa, Kenji Momo, Tadanori Sasaki, Hitoshi Yoshida
A Case of Hepatocellular Carcinoma Successfully Resumed Atezolizumab and Bevacizumab After Associated Grade 3 Diarrhea and Grade 2 Colitis: Case Report and Literature Review. OncoTargets and therapy 15 (2022)